cache/a82e464d5c6271b8c306a6670397f24fbe55c80ebd72e4534d6d0f3ef8779a2f

COM:NEURENATI

Neurenati

  • Privately Held

Neurenati is a biotechnology company developing a treatment for Hirschsprung's disease, which affects the enteric nervous system in patients, primarily young children. The treatment aims to improve intestinal functions and promote regeneration.

investor of

competitor of